"drugdevelopR: Planning of phase II/III drug development programs with ..."

Johannes Cepicka et al. (2025)

> Home

Details and statistics

DOI: 10.1016/J.SOFTX.2025.102066

access: open

type: Journal Article

metadata version: 2025-04-01

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/softx/CepickaSKKE25
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/softx/CepickaSKKE25
Johannes Cepicka, Lukas D. Sauer, Marietta Kirchner, Meinhard Kieser, Stella Erdmann:
drugdevelopR: Planning of phase II/III drug development programs with optimal sample size allocation and Go/No-go decision rules in R. SoftwareX 30: 102066 (2025)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.